ScholarLens Back to search
2010•Journal of Shandong Medical CollegeRequires access

COST-EFFECTIVENESS ANALYSIS OF GATIFLOXACIN AND LEVOFLOXACIN IN THE TREATMENT OF LOWER RESPIRATORY TRACT INFECTIONS

Yufeng Wang

Open publisher page 0 citations

Abstract

Objective To evaluate the cost-effectiveness of gatofloxacin and levofloxacin injections in the treatment of lower respiratory tract infections in order to provide rational use of the drugs and to reduce the treatment cost.Methods Pharmacoeconomic cost-effectoveness analysis of gatifloxacin and levofloxacin in the treatment of lower respiratory tract infections was made.Results There was no obvious difference between the uses of the two drugs in terms of the clinical effective rate,the curative rate and the bacterial clearance rate in the treatment of the lower respiratory tract infections,but the cost-effectiveness ratio of levofloxacin was superior to that of gatifloxacin.Conclusion The use of levoflxacin can produce better cost-effectiveness ratio in the treatment lower respiratory tract infections than the use of gatifloxacin.

About this research paper

What this paper is about

Objective To evaluate the cost-effectiveness of gatofloxacin and levofloxacin injections in the treatment of lower respiratory tract infections in order to provide rational use of the drugs and to reduce the treatment cost.Methods Pharmacoeconomic cost-effectoveness analysis of gatifloxacin and levofloxacin in the treatment of lower respiratory tract infections was made.Results There was no obvious difference between the uses of the two drugs in terms of the clinical effective rate,the curative rate and the bacterial clearance rate in the treatment of the lower respiratory tract infections,but the cost-effectiveness ratio of levofloxacin was superior to that of gatifloxacin.Conclusion The use of levoflxacin can produce better cost-effectiveness ratio in the treatment lower respiratory tract infections than the use of gatifloxacin.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the cost-effectiveness of gatofloxacin and levofloxacin injections in the treatment of lower respiratory tract infections in order to provide rational use of the drugs and to reduce the treatment cost.Methods Pharmacoeconomic cost-effectoveness analysis of gatifloxacin and levofloxacin in the treatment of lower respiratory tract infections was made.Results There was no obvious difference between the uses of the two drugs in terms of the clinical effective rate,the curative rate and the bacterial clearance rate in the treatment of the lower respiratory tract infections,but the cost-effectiveness ratio of levofloxacin was superior to that of gatifloxacin.Conclusion The use of levoflxacin can produce better cost-effectiveness ratio in the treatment lower respiratory tract infections than the use of gatifloxacin.

Key concepts: Gatifloxacin, Levofloxacin, Medicine, Respiratory tract infections, Respiratory tract, Intensive care medicine, Respiratory system, Internal medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
COST-EFFECTIVENESS ANALYSIS OF GATIFLOXACIN AND LEVOFLOXACIN IN THE TREATMENT OF LOWER RESPIRATORY TRACT INFECTIONS — Research Paper | ScholarLens